Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity.

Tye-Din JA, Skodje GI, Sarna VK, Dzuris JL, Russell AK, Goel G, Wang S, Goldstein KE, Williams LJ, Sollid LM, Lundin KE, Anderson RP.

United European Gastroenterol J. 2020 Feb;8(1):108-118. doi: 10.1177/2050640619874173. Epub 2019 Sep 3.

2.

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.

Daveson AJM, Tye-Din JA, Goel G, Goldstein KE, Hand HL, Neff KM, Williams LJ, Truitt KE, Anderson RP; RESET CeD Study Group.

Aliment Pharmacol Ther. 2020 Jan;51(2):244-252. doi: 10.1111/apt.15551. Epub 2019 Nov 26.

PMID:
31769533
3.

Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.

Tye-Din JA, Daveson AJM, Ee HC, Goel G, MacDougall J, Acaster S, Goldstein KE, Dzuris JL, Neff KM, Truitt KE, Anderson RP.

Aliment Pharmacol Ther. 2019 Oct;50(8):901-910. doi: 10.1111/apt.15477. Epub 2019 Sep 4.

PMID:
31483515
4.

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.

Goel G, Tye-Din JA, Qiao SW, Russell AK, Mayassi T, Ciszewski C, Sarna VK, Wang S, Goldstein KE, Dzuris JL, Williams LJ, Xavier RJ, Lundin KEA, Jabri B, Sollid LM, Anderson RP.

Sci Adv. 2019 Aug 7;5(8):eaaw7756. doi: 10.1126/sciadv.aaw7756. eCollection 2019 Aug.

5.

Reprint of: F-18Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: The legacy of Monte S. Buchsbaum, M.D.

Hazlett EA, Vaccaro DH, Haznedar MM, Goldstein KE.

Psychiatry Res. 2019 Jul;277:39-44. doi: 10.1016/j.psychres.2019.06.014. Epub 2019 Jun 20. Review.

PMID:
31229307
6.

Short communication: Diffusion tensor anisotropy in the cingulate in borderline and schizotypal personality disorder.

Goldstein KE, Haznedar MM, Alloy LB, Drabick DAG, McClure MM, New AS, Chu KW, Vaccaro D, Tang CY, Meyerson D, Hazlett EA.

Psychiatry Res. 2019 Sep;279:353-357. doi: 10.1016/j.psychres.2019.05.016. Epub 2019 May 14.

PMID:
31101379
7.

F-18Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: The legacy of Monte S. Buchsbaum, M.D.

Hazlett EA, Vaccaro DH, Haznedar MM, Goldstein KE.

Psychiatry Res. 2019 Jan;271:535-540. doi: 10.1016/j.psychres.2018.12.030. Epub 2018 Dec 7. Review.

PMID:
30553101
8.

Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Daveson AJM, Ee HC, Andrews JM, King T, Goldstein KE, Dzuris JL, MacDougall JA, Williams LJ, Treohan A, Cooreman MP, Anderson RP.

EBioMedicine. 2017 Dec;26:78-90. doi: 10.1016/j.ebiom.2017.11.018. Epub 2017 Nov 22.

9.

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.

Goel G, King T, Daveson AJ, Andrews JM, Krishnarajah J, Krause R, Brown GJE, Fogel R, Barish CF, Epstein R, Kinney TP, Miner PB Jr, Tye-Din JA, Girardin A, Taavela J, Popp A, Sidney J, Mäki M, Goldstein KE, Griffin PH, Wang S, Dzuris JL, Williams LJ, Sette A, Xavier RJ, Sollid LM, Jabri B, Anderson RP.

Lancet Gastroenterol Hepatol. 2017 Jul;2(7):479-493. doi: 10.1016/S2468-1253(17)30110-3. Epub 2017 May 11.

10.

Brain-derived neurotrophic factor Val66Met genotype modulates amygdala habituation.

Perez-Rodriguez MM, New AS, Goldstein KE, Rosell D, Yuan Q, Zhou Z, Hodgkinson C, Goldman D, Siever LJ, Hazlett EA.

Psychiatry Res Neuroimaging. 2017 May 30;263:85-92. doi: 10.1016/j.pscychresns.2017.03.008. Epub 2017 Mar 24.

11.

Cognitive Styles in Mood Disorders: Discriminative Ability of Unipolar and Bipolar Cognitive Profiles.

Shapero BG, Stange JP, Goldstein KE, Black CL, Molz AR, Hamlat EJ, Black SK, Boccia AS, Abramson LY, Alloy LB.

Int J Cogn Ther. 2015 Mar;8(1):35-60.

12.

Dialectical behavior therapy alters emotion regulation and amygdala activity in patients with borderline personality disorder.

Goodman M, Carpenter D, Tang CY, Goldstein KE, Avedon J, Fernandez N, Mascitelli KA, Blair NJ, New AS, Triebwasser J, Siever LJ, Hazlett EA.

J Psychiatr Res. 2014 Oct;57:108-16. doi: 10.1016/j.jpsychires.2014.06.020. Epub 2014 Jul 2.

13.

Behavioral approach system sensitivity and risk taking interact to predict left-frontal EEG asymmetry.

Black CL, Goldstein KE, LaBelle DR, Brown CW, Harmon-Jones E, Abramson LY, Alloy LB.

Behav Ther. 2014 Sep;45(5):640-50. doi: 10.1016/j.beth.2014.01.006. Epub 2014 Jan 30.

14.

White matter abnormalities in schizophrenia and schizotypal personality disorder.

Lener MS, Wong E, Tang CY, Byne W, Goldstein KE, Blair NJ, Haznedar MM, New AS, Chemerinski E, Chu KW, Rimsky LS, Siever LJ, Koenigsberg HW, Hazlett EA.

Schizophr Bull. 2015 Jan;41(1):300-10. doi: 10.1093/schbul/sbu093. Epub 2014 Jun 23.

15.

Visual-spatial working memory performance and temporal gray matter volume predict schizotypal personality disorder group membership.

Hazlett EA, Lamade RV, Graff FS, McClure MM, Kolaitis JC, Goldstein KE, Siever LJ, Godbold JH, Moshier E.

Schizophr Res. 2014 Feb;152(2-3):350-7. doi: 10.1016/j.schres.2013.12.006. Epub 2014 Jan 4.

PMID:
24398009
16.

Anterior limb of the internal capsule in schizotypal personality disorder: fiber-tract counting, volume, and anisotropy.

Hazlett EA, Collazo T, Zelmanova Y, Entis JJ, Chu KW, Goldstein KE, Roussos P, Haznedar MM, Koenigsberg HW, New AS, Buchsbaum MS, Hershowitz JP, Siever LJ, Byne W.

Schizophr Res. 2012 Nov;141(2-3):119-27. doi: 10.1016/j.schres.2012.08.022. Epub 2012 Sep 18.

17.

Cognitive vulnerabilities and depression versus other psychopathology symptoms and diagnoses in early adolescence.

Alloy LB, Black SK, Young ME, Goldstein KE, Shapero BG, Stange JP, Boccia AS, Matt LM, Boland EM, Moore LC, Abramson LY.

J Clin Child Adolesc Psychol. 2012;41(5):539-60. doi: 10.1080/15374416.2012.703123. Epub 2012 Aug 1.

18.

Potentiated amygdala response to repeated emotional pictures in borderline personality disorder.

Hazlett EA, Zhang J, New AS, Zelmanova Y, Goldstein KE, Haznedar MM, Meyerson D, Goodman M, Siever LJ, Chu KW.

Biol Psychiatry. 2012 Sep 15;72(6):448-56. doi: 10.1016/j.biopsych.2012.03.027. Epub 2012 May 4.

19.

A review of structural MRI and diffusion tensor imaging in schizotypal personality disorder.

Hazlett EA, Goldstein KE, Kolaitis JC.

Curr Psychiatry Rep. 2012 Feb;14(1):70-8. doi: 10.1007/s11920-011-0241-z. Review.

20.

Anterior and posterior cingulate cortex volume in healthy adults: effects of aging and gender differences.

Mann SL, Hazlett EA, Byne W, Hof PR, Buchsbaum MS, Cohen BH, Goldstein KE, Haznedar MM, Mitsis EM, Siever LJ, Chu KW.

Brain Res. 2011 Jul 15;1401:18-29. doi: 10.1016/j.brainres.2011.05.050. Epub 2011 May 27.

21.

Cingulate and temporal lobe fractional anisotropy in schizotypal personality disorder.

Hazlett EA, Goldstein KE, Tajima-Pozo K, Speidel ER, Zelmanova Y, Entis JJ, Silverman JM, New AS, Koenigsberg HW, Haznedar MM, Byne W, Siever LJ.

Neuroimage. 2011 Apr 1;55(3):900-8. doi: 10.1016/j.neuroimage.2010.12.082. Epub 2011 Jan 9.

22.

Dorso- and ventro-lateral prefrontal volume and spatial working memory in schizotypal personality disorder.

Goldstein KE, Hazlett EA, Savage KR, Berlin HA, Hamilton HK, Zelmanova Y, Look AE, Koenigsberg HW, Mitsis EM, Tang CY, McNamara M, Siever LJ, Cohen BH, New AS.

Behav Brain Res. 2011 Apr 15;218(2):335-40. doi: 10.1016/j.bbr.2010.11.042. Epub 2010 Nov 27.

23.

Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder.

New AS, Hazlett EA, Newmark RE, Zhang J, Triebwasser J, Meyerson D, Lazarus S, Trisdorfer R, Goldstein KE, Goodman M, Koenigsberg HW, Flory JD, Siever LJ, Buchsbaum MS.

Biol Psychiatry. 2009 Dec 15;66(12):1107-14. doi: 10.1016/j.biopsych.2009.07.015. Epub 2009 Sep 12.

24.

FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.

Buchsbaum MS, Haznedar M, Newmark RE, Chu KW, Dusi N, Entis JJ, Goldstein KE, Goodman CR, Gupta A, Hazlett E, Iannuzzi J, Torosjan Y, Zhang J, Wolkin A.

Schizophr Res. 2009 Oct;114(1-3):161-71. doi: 10.1016/j.schres.2009.07.015. Epub 2009 Aug 19.

PMID:
19695836
25.

Smaller superior temporal gyrus volume specificity in schizotypal personality disorder.

Goldstein KE, Hazlett EA, New AS, Haznedar MM, Newmark RE, Zelmanova Y, Passarelli V, Weinstein SR, Canfield EL, Meyerson DA, Tang CY, Buchsbaum MS, Siever LJ.

Schizophr Res. 2009 Jul;112(1-3):14-23. doi: 10.1016/j.schres.2009.04.027. Epub 2009 May 26.

26.

Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients.

Hazlett EA, Buchsbaum MS, Haznedar MM, Newmark R, Goldstein KE, Zelmanova Y, Glanton CF, Torosjan Y, New AS, Lo JN, Mitropoulou V, Siever LJ.

Schizophr Res. 2008 Apr;101(1-3):111-23. doi: 10.1016/j.schres.2007.12.472. Epub 2008 Feb 13.

27.

FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol.

Buchsbaum MS, Haznedar MM, Aronowitz J, Brickman AM, Newmark RE, Bloom R, Brand J, Goldstein KE, Heath D, Starson M, Hazlett EA.

Schizophr Res. 2007 Aug;94(1-3):293-305. Epub 2007 Jun 15.

PMID:
17574821
28.

Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum.

Hazlett EA, Romero MJ, Haznedar MM, New AS, Goldstein KE, Newmark RE, Siever LJ, Buchsbaum MS.

Schizophr Res. 2007 Jul;93(1-3):288-95. Epub 2007 May 2.

PMID:
17478083
29.

Supplemental Content

Loading ...
Support Center